Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds specifically-identified oligosaccharide structure
Reexamination Certificate
2005-04-26
2005-04-26
Smith, L. F. (Department: 1645)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Binds specifically-identified oligosaccharide structure
C424S130100, C424S135100, C424S136100, C424S137100, C424S142100, C424S143100, C424S145100, C424S149100, C424S156100, C424S164100, C424S178100, C424S184100, C435S329000, C435S332000, C435S334000, C435S344100, C436S512000, C436S547000, C436S548000
Reexamination Certificate
active
06884417
ABSTRACT:
The present invention concerns a method of treating LBP-mediated LPS-induced myeloid cell activation comprising administering a therapeutically effective amount of an anti-LBP monoclonal antibody molecule. A therapeutic composition comprising anti-LBP antibody molecules in a pharmaceutically acceptable excipient is also contemplated.
REFERENCES:
patent: 5753504 (1998-05-01), Kirkland et al.
Leturcq et al. 1992. J. Cell. Biochem. 16C:161.*
Martin et al. 1992. J. Clin. Investigations. 90:2209-2219.*
Pugin et al. 1993, PNAS. 90:2744-2448.*
Gallay, et al., “Competition Between LPS-Binding Protein (LBP) and Anti-LPS Antibody in LPS-Induced TNF Secretion of Human Monocytes (MO)”,Experientia 48: p. A66, Abstract 384 (1992).
Harlow, et al., “Antibodies: A Laboratory Manual” (1998).
Landmann, et al., “Effect of Cytokines and Lipopolysaccharide on CD14 Antigen Expression in Human Monocytes and Macrophages”,J. of Cell. Biochem. 47: 317-329.
Leturcq, et al., “Generation of Monoclonal Antibodies to Human LBP and Their Use in the Detection of LBP Protein in Serum”,Journal of Cellular Biochemistry, Supplement 16, Part C, p. 161, Abstract CB109 (1992).
Martin, et al., “Lipopolysaccharide Binding Protein Enhances the Responsivesness of Alveolar Macrophages to Bacterial Lipopolysaccharide”,Journal of Clinical Investigations 90: 2209-2219 (1992).
Pugin, et al., “Lipopolysaccharide Activation of Human Endothelial and Epithelial Cells is Mediated by Lipopolysaccharide-Binding Protein and Soluble CD14”,Proc. Natl. Acad. Sci. USA 90: 2744-2748 (1993).
Schutt, et al., “Human Monocyte Activation Induced by an Anti-Monoclonal Antibody”,Immuno. Letters 19: 321-328 (1988).
Tobias, et al., “Participation of Lipopolysaccharide-binding Protein in Lipopolysaccharide-dependent Macrophage Activation”,Am. J. Respir. Cell Mol. Biol. 7: 239-245 (1992).
Waldmann, “Monoclonal Antibodies in Diagnosis and Therapy”,Science 252: 1657-1662 (1991).
Weir, “Vol. 3 Application of Immunological Methods”,Blackwell Scientific Publicaitons(1978).
Tobias, et al., “Isolation of a Lipopolysaccharide-Binding Acute Phase Reactant From Rabbit Serum”,J. Exp. Med., 164: 777-793 (1986).
Tobias, et al., “Identification of a Lipid A Binding Site in the Acute Phase Reactant Lipopolysaccharide Binding Protein”,J. Biol. Chem., 264: 10867-10871 (1989).
Wright, et al., “CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding Protein”,Science, 249: 1431-1433 (1990).
Schumann, et al., “Structure and Function of Lipopolysaccharide Binding Protein”,Science, 249: 1429-1431 (1990).
Kirkland Theo
Leturcq Didier
Moriarty Ann
Tobias Peter
Ulevitch Richard
Fitting Thomas
Hines J.
McCarthy Michael J.
Smith L. F.
The Scripps Research Institute
LandOfFree
Monoclonal antibodies immunoreactive with lipopolysaccharide... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monoclonal antibodies immunoreactive with lipopolysaccharide..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibodies immunoreactive with lipopolysaccharide... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3435582